CC

Catherine Elisabeth Charron

RE Respivert: 4 patents #5 of 28Top 20%
TL Topivert Pharma Limited: 1 patents #5 of 19Top 30%
Overall (2016): #46,605 of 481,213Top 10%
4
Patents 2016

Issued Patents 2016

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
9475796 1-pyrazolyl-3-((4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitors Kazuhiro Ito, John King-Underwood, Stuart Thomas Onions, Alistair Ian Longshaw 2016-10-25
9260410 P38 MAP kinase inhibitors John King-Underwood, Kazuhiro Ito, Peter Strong, William Garth Rapeport, Peter John Murray +2 more 2016-02-16
9249125 Pyrazole derivatives as p38 MAP inhibitors Lorna Duffy, John King-Underwood, Alistair Ian Longshaw, Peter John Murray, Stuart Thomas Onions +3 more 2016-02-02
9242960 P38MAP kinase inhibitors Kazuhiro Ito, Peter Strong, William Garth Rapeport, Peter John Murray, John King-Underwood +2 more 2016-01-26